Voloridge Investment Management
BBIO icon

Voloridge Investment Management’s BridgeBio Pharma BBIO Stock Holding History

Voloridge Investment Management’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-426,583
Closed -$31.7M – 824
2026
Q1 		$31.7M Sell
426,583
-212,300
-33% -$15.4M 0.13% 233
2025
Q4 		$48.9M Buy
638,883
+505,051
+377% +$33.2M 0.17% 152
2025
Q3 		$6.95M Buy
+133,832
New +$6.53M 0.02% 645
2024
Q3 		– Sell
-353,961
Closed -$8.97M – 1162
2024
Q2 		$8.97M Sell
353,961
-1,042,458
-75% -$28.5M 0.03% 590
2024
Q1 		$43.2M Buy
1,396,419
+290,430
+26% +$9.88M 0.16% 187
2023
Q4 		$44.6M Sell
1,105,989
-143,669
-11% -$4.31M 0.18% 159
2023
Q3 		$33M Buy
1,249,658
+770,207
+161% +$21.9M 0.16% 172
2023
Q2 		$8.25M Sell
479,451
-563,035
-54% -$8.47M 0.04% 518
2023
Q1 		$17.3M Buy
1,042,486
+411,775
+65% +$4.8M 0.09% 325
2022
Q4 		$4.81M Sell
630,711
-190,350
-23% -$1.82M 0.03% 651
2022
Q3 		$8.16M Buy
821,061
+730,510
+807% +$7.59M 0.04% 507
2022
Q2 		$822K Sell
90,551
-351,412
-80% -$2.94M ﹤0.01% 1234
2022
Q1 		$4.49M Buy
441,963
+206,545
+88% +$2.12M 0.03% 674
2021
Q4 		$3.93M Buy
+235,418
New +$9.96M 0.02% 802
2021
Q1 		– Sell
-119,021
Closed -$8.46M – 1391
2020
Q4 		$8.46M Sell
119,021
-34,854
-23% -$1.68M 0.07% 318
2020
Q3 		$5.77M Buy
153,875
+95,934
+166% +$3.02M 0.05% 411
2020
Q2 		$1.89M Buy
+57,941
New +$1.76M 0.02% 642

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Voloridge Investment Management's BBIO Position: Q2 2026 in Review

Voloridge Investment Management sold out of BridgeBio Pharma (BBIO) in Q2 2026, closing a stake of 426,583 shares — an estimated $31.7M sold.

Voloridge Investment Management first reported a position in BBIO in Q2 2020 and held it in 17 quarters. The position peaked at $48.9M in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Voloridge Investment Management reported no remaining BridgeBio Pharma position as of Q2 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 426,583 BridgeBio Pharma shares in Q2 2026, an estimated $31.7M.
  • Voloridge Investment Management first reported a position in BridgeBio Pharma in Q2 2020 and held it in 17 quarters.
  • Voloridge Investment Management's BridgeBio Pharma position peaked at $48.9M in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.